In order to further improve the level of diagnosis and treatment of acute leukemia-related diseases, so that the majority of medical staff understand the new developments and new technologies of AML treatment, and strengthen academic exchanges in the department of hematology. After research, the Chengdu High-tech Medical Association "2021 Midwest Acute Leukemia Diagnosis and Treatment Conference" is scheduled to be held online on August 22, 2021.

The chairmen of the conference, Professor Lai Yongrong and Professor Xia Linghui gave an opening speech and summary in the morning meeting. The speech and summary in the afternoon session were conducted by Professor Huang Xiaobing and Professor Tan Jing. In terms of academic content sharing, Professor Huang Ying from the First Affiliated Hospital of Kunming Medical University shared the "New Progress in EHA 2021 AML Diagnosis and Treatment"; Professor Xu Fang from Mianyang Central Hospital explained the "Application Selection and Management of HiDAC Chemotherapy in AML"; Professor Huang Wei from Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology analyzed "Challenges and mechanisms of first-line induction therapy for AML patients with classic 7+3 regimens in the era of new drugs"; Lu Yinghao, Affiliated Hospital of Guizhou Medical University Professor Wu Qiuling from Tongji Medical College Affiliated Hospital of Huazhong University of Science and Technology shared the "New Advances in Fit Elderly AML Chemotherapy"; Professor Song Jun from Guizhou Provincial People’s Hospital introduced Professor Wang Li from the First Affiliated Hospital of Chongqing Medical University conducted online analysis based on the "New Advances in Treatment of Elderly AML"; Professor Liu Rongrong from the First Affiliated Hospital of Guangxi Medical University commented on the "Based on Dynamic MRD The Stratified Treatment of AML" carried out an in-depth analysis and explanation.

The conference hired famous AML therapists across the country to give lectures, covering a wide range of topics, to update the knowledge structure of the vast number of hematology clinicians and their colleagues in related fields, carry out related translational medicine research, and play a positive role in grasping the development trends at home and abroad And the leading role is worth learning from the majority of grassroots physicians.